About
Since inception, the company have been focused on building strategic value for their investments especially for expansion plans to the US and China.
Apart from that the company is engaging in various Real Estate related Projects.
DML Capital was established in 2010 as a holding and consulting company for various early stage investments. The investments in companies are mainly in life-science related industries.
​
The Real Estate investments are mainly in Germany with a long-term focus on development.
Daniel Mahnert-Lueg
Managing Director
Daniel has around 28 years of experience working in the fields of investments, sales and operations. For 15 Years he worked as a partner in a Private Equity company to buy companies in the Life-science sector with special focus on expanding these companies to the US and China.
In the past he worked for Pfizer in Shanghai helping them launch a new product line. Before that he worked in the field of Private Equity in Hong Kong for AEA Investors. He has launched two companies in the past and was part of the Board of Directors of Genesis, a public Biotech group in New Zealand.
Daniel graduated with an MBA from CEIBS and a bachelors from New York University. He lived 10 years in the US and 13 years in China and Hong Kong and speaks fluent Mandarin.